
Sign up to save your podcasts
Or


Here is what you need to know about the new ETFs that capitalize on Covid-19 themes
(1:30) - ETFMG Treatments Testing and Advancements ETF: GERM
(5:15) - Why Is Testing In The U.S. Such A Big Problem?
(12:20) - What Are Major Companies Working On Right Now For Covid-19?
(16:30) - Expected Growth For The Vaccine Market: Is This A Long Term Play?
(19:20) - What Are The Current Treatments For Covid-19?
(24:00) - Pacer Biothreat Strategy ETF: VIRS
(29:30) - How Are The Holdings Selected and Weighting For VIRS?
(33:40) - How Does VIRS Fit Into An Investor's Portfolio
[email protected]
By Zacks Investment Research4.6
6969 ratings
Here is what you need to know about the new ETFs that capitalize on Covid-19 themes
(1:30) - ETFMG Treatments Testing and Advancements ETF: GERM
(5:15) - Why Is Testing In The U.S. Such A Big Problem?
(12:20) - What Are Major Companies Working On Right Now For Covid-19?
(16:30) - Expected Growth For The Vaccine Market: Is This A Long Term Play?
(19:20) - What Are The Current Treatments For Covid-19?
(24:00) - Pacer Biothreat Strategy ETF: VIRS
(29:30) - How Are The Holdings Selected and Weighting For VIRS?
(33:40) - How Does VIRS Fit Into An Investor's Portfolio
[email protected]

3,217 Listeners

944 Listeners

521 Listeners

296 Listeners

198 Listeners

101 Listeners

354 Listeners

930 Listeners

85 Listeners

1,561 Listeners

213 Listeners

73 Listeners

341 Listeners

56 Listeners

48 Listeners